Skip to main navigation
logo
Logo

Site - Top Nav

  • About Iveric
  • Our Commitment
  • Why Iveric?
  • Clinical Programs
  • Investor Relations
  • Contact Us

Site - IR Nav

  • Investor Relations
  • News
  • Events & Presentations
  • Corporate Governance
    • Leadership
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Key Ratios
  • IRS Form 8937
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Analyst Coverage
  • Investor FAQs
  • Contact Us

Press Releases

06.09.2021
Iveric Bio to Host Investor Symposium on Dry Age-Related Macular Degeneration on June 18, 2021
05.05.2021
Iveric Bio Reports First Quarter 2021 Operational Highlights and Financial Results
05.04.2021
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04.28.2021
Iveric Bio to Report First Quarter 2021 Financial Results and Host Conference Call on Wednesday, May 5, 2021
04.05.2021
David R. Guyer, MD to Step Down from Iveric Bio Board to Rejoin Venture Fund
04.01.2021
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03.16.2021
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03.03.2021
Iveric Bio Reports Fourth Quarter and Year End 2020 Operational Highlights and Financial Results
03.02.2021
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02.25.2021
Iveric Bio to Present at the Cowen 41st Annual Health Care Conference

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page next ›
  • Last page last »

Site - Shareholder Tools

Printed Materials
Printed Materials
Email Alerts
Email Alerts
Downloads
Downloads
RSS Feeds
RSS Feeds
Print
Print
Share This
Share This
Twitter
Twitter

Site - Footer Nav

  • Contact Us
  • Careers
  • Expanded Access
  • Privacy Policy
  • Sitemap